In the bone microenvironment, cancer cells expressing C2GnT disrupts the ligand-receptor-mediated (NKR/NKR-L and TRAIL/DR4) immune response blocking the apoptosis of cancer cells [82]. Here, TNFSF10 is linked to cancer.